Current Medicinal Chemistry
The rate of people dropping out of the trial was higher than what was seen for Zepbound but similar to rates seen with Wegovy, Lilly said
However, a new case report highlights a hidden side effect associated with this popular medication, revealing how the drug appears to sap patients motivation and energy, resulting in emotional flatness." In addition to altering users metabolism, GLP-1s treat obesity by reducing the incentive to eat through the brain's dopaminergic reward system
Concentration and formulation quality dramatically impact both treatment effectiveness and post-discontinuation durability
Reduces Water RetentionHelps eliminate excess water from the body, promoting a leaner and more defined appearance
J Laparoendosc Adv Surg Tech A 2007;17:2725.Google Scholar Schulster, ML, Cohn, MR, Najari, BB, Goldstein, M